• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Chartmill

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Gapping S&P500 stocks in Tuesday's session ↗
    Via Chartmill
    Tickers DELL ETN GLW GNRC INTC MU
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Tickers AMBQ BWEN BZFD CNCK CVM ELPW
    SAB Biotherapeutics (NASDAQ:SABS) Reports Q1 2026 Miss as Clinical Progress and Extended Cash Runway Through 2028 Take Center Stage ↗
    Via Chartmill
    Tickers SABS
    SFL CORP LTD (NYSE:SFL) Beats Q1 Estimates, Hikes Dividend for 89th Consecutive Quarter ↗
    Via Chartmill
    Tickers SFL
    Sleep Number Corp (NASDAQ:SNBR) Reports Q1 2026 Loss, Revenue Misses Estimates ↗
    Via Chartmill
    Tickers SNBR
    TON Strategy Co. (NASDAQ:TONX) Surges After Q1 Revenue Beat and Staking Yield Milestone ↗
    Via Chartmill
    Tickers TONX
    IceCure Medical (NASDAQ:ICCM) Shares Slide Over 7% Premarket After Q1 Revenue Miss ↗
    Via Chartmill
    Tickers ICCM
    NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗
    Via Chartmill
    Tickers NMTC
    ACCS Misses Q1 Estimates, Subscription Strength Fails to Offset Revenue Decline ↗
    Via Chartmill
    Tickers ACCS
    Netlist (NASDAQ:NLST) Q1 Earnings Beat Sparks 16% Sell-Off ↗
    Via Chartmill
    Topics Earnings
    Tickers NLST
    XOMA Royalty Corporation (NASDAQ:XOMA) Checks Nearly Every Box in Louis Navellier’s Eight-Rule Growth Stock Screen ↗
    Via Chartmill
    Tickers XOMA
    EOG Resources Inc (NYSE:EOG) is a Compelling Value Pick with Strong Financial Health and Profitability. ↗
    Via Chartmill
    Tickers EOG
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    Tickers AMD APA COHR HOOD INTC J
    Neurocrine Biosciences (NASDAQ:NBIX) Screens as a Peter Lynch-Style GARP Opportunity ↗
    Via Chartmill
    Tickers NBIX
    Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
    Via Chartmill
    Tickers AMBO BZFD CNCK CREG CVM GTM
    Under Armour Inc-CLASS A (NYSE:UAA) Plunges After Q4 Earnings Miss and Weak Fiscal 2027 Guidance ↗
    Via Chartmill
    Topics Earnings
    Tickers UAA
    Vestis Corp (NYSE:VSTS) Q2 Earnings Beat, Upgrades Full-Year Guidance ↗
    Via Chartmill
    Topics Earnings
    Tickers VSTS
    Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short ↗
    Via Chartmill
    Tickers LEGN
    D-Wave Quantum Inc. (NYSE:QBTS) Q1 Revenue Misses but Record Bookings Send Stock Higher ↗
    Via Chartmill
    Tickers QBTS
    Veritone (VERI) Plunges After Q1 Revenue Miss but Reaffirms Full-Year Growth Targets ↗
    Via Chartmill
    Tickers VERI
    Camtek (NASDAQ:CAMT) Q1 2026 Results Inline with Estimates, Shares Dip on Mixed Guidance ↗
    Via Chartmill
    Tickers CAMT
    Tenax Therapeutics (NASDAQ:TENX) Q1 2026 Slightly Beats EPS, Gears Up for Pivotal Phase 3 Data in Q3 ↗
    Via Chartmill
    Tickers TENX
    Janus International Group (NYSE:JBI) Q1 Results: Revenue Beat Overshadowed by EPS Miss ↗
    Via Chartmill
    Tickers JBI
    Arvinas (NASDAQ:ARVN) Q1 2026 Results: First-Ever PROTAC Approval Offsets Revenue Miss ↗
    Via Chartmill
    Tickers ARVN
    ACHV Stock Surges After Achieve Life Sciences Reports Market-Beating Q1 2026 Earnings ↗
    Via Chartmill
    Tickers ACHV
    Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
    Via Chartmill
    Tickers HBIO
    Olema Pharmaceuticals (NASDAQ:OLMA) Reports Narrower Q1 Loss, Eyes Fall Breast Cancer Data Readout ↗
    Via Chartmill
    Tickers OLMA
    Prelude Therapeutics (NASDAQ:PRLD) Reports Narrower Quarterly Loss, Shares Rise on Cash Runway Extension ↗
    Via Chartmill
    Tickers PRLD
    Acumen Pharmaceuticals (NASDAQ:ABOS) Q1 2026 Loss Narrows as Phase 2 Alzheimer's Trial Readout Looms ↗
    Via Chartmill
    Tickers ABOS
    Broadwind Inc. (NASDAQ:BWEN) Surges After Q1 2026 Earnings Beat ↗
    Via Chartmill
    Tickers BWEN
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.